Premium
InvAscent, a homegrown private equity firm focused on healthcare bets across the country, has struck a fresh investment in a diagnostics firm from its latest fund, the India Life Sciences Fund III. The PE firm, with an AUM (assets under management of over $500 million, also recently made a second exit ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
